Skip to main content
. Author manuscript; available in PMC: 2023 Jan 12.
Published in final edited form as: J Vasc Surg. 2021 Apr 2;74(4):1232–1239.e3. doi: 10.1016/j.jvs.2021.03.017

Table IV.

Patency of diabetic limbs requiring major amputation at 1 year stratified by quartile of estimated benefit of revascularizationa

Quartile 1-year Major
amputation
Revascularization
patent at major
amputation
Overall 16/137 (11.7) 9/16 (56.3)
Q1 (highest benefit) 3/34 (8.8) 1/3 (33.3)
Q2 (moderate benefit) 2/42 (4.8) 2/2 (100)
Q3 (low benefit) 2/39 (6.7) 0/2 (0)
Q4 (questionable benefit) 9/31 (29.0) 6/9 (66.7)

Q, Quartile.

Data presented as number per total (%).

a

Total number of patients was 137 because those without 1 year of follow-up were excluded from the subanalysis.